Loading...
•
Dec 31, 2021
Integra LifeSciences Q4 2021 Earnings Report
Reported an increase in revenue and adjusted earnings per diluted share remained flat compared to the fourth quarter of 2020.
Key Takeaways
Integra LifeSciences reported a revenue increase of 4.3% on a reported basis and 8.3% on an organic basis for Q4 2021. GAAP earnings per diluted share were $0.53, while adjusted earnings per diluted share were $0.84, flat compared to Q4 2020.
Reported revenues increased by 4.3% on a reported basis and 8.3% on an organic basis compared to Q4 2020.
GAAP earnings per diluted share were $0.53, compared to $1.09 in Q4 2020.
Adjusted earnings per diluted share were $0.84, flat compared to Q4 2020.
Adjusted EBITDA for Q4 2021 was $105.4 million, compared to $102.7 million in Q4 2020.
Forward Guidance
The Company’s guidance for 2022 revenue and adjusted earnings per share reflects the continuing uncertainty around the scope and duration of the pandemic, and its related impacts on our business in the first half of the year.
Positive Outlook
- Full-year 2022 revenue is expected to be in the range of $1,580 million to $1,600 million, representing reported growth of approximately 2.5% to 3.5%.
- Full-year 2022 organic growth is expected to be approximately 3.5% to 5%.
- Adjusted earnings per diluted share are expected to be in a range of $3.27 to $3.35 for full-year 2022.
- The company entered into an accelerated share repurchase agreement with Citibank, N.A. to repurchase $125 million in the aggregate.
- The repurchase transactions are expected to be completed in the first half of 2022.
Challenges Ahead
- First quarter 2022 reported revenues are expected to be in the range of $357 million to $365 million, representing reported growth of approximately -1% to 1.5%.
- First quarter 2022 organic growth is expected to be approximately 0% to 2.5%.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...